Clinical characterization of autoimmune LGI1 antibody limbic encephalitis

Epilepsy and Behavior

Volumn 56, Issue , 2016, Pages 165-169

  Gao, Lehong ^a   Liu, Aihua ^a   Zhan, Shuqin ^a   Wang, Li ^a   Li, Liping ^a   Guan, Le ^a   Zhao, Xin ^a   Zhang, Xiating ^a   Wang, Yuping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune encephalitis; LGI1; Limbic encephalitis

Indexed keywords

BRAIN ANTIBODY; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY; UNCLASSIFIED DRUG; ANTICONVULSIVE AGENT; AUTOANTIBODY; BIOLOGICAL MARKER; LGI1 PROTEIN, HUMAN; PROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULA; MAGNETOENCEPHALOGRAPHY; MALE; MIDDLE AGED; PARANEOPLASTIC NEUROPATHY; RETROSPECTIVE STUDY; SEIZURE; SEX RATIO; SPIKE WAVE; SYLVIAN FISSURE; TEMPORAL LOBE; AUTOIMMUNE DISEASES; BLOOD; COHORT ANALYSIS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; METABOLISM; PROCEDURES; TREATMENT OUTCOME; TRENDS;

ADULT; AGED; ANTICONVULSANTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOMARKERS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MAGNETOENCEPHALOGRAPHY; MALE; MIDDLE AGED; PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84960407754     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.12.041     Document Type: Article

References (29)

1. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
2. Hughes E.G., Peng X., Gleichman A.J., Lai M., Zhou L., Tsou R., et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010, 30:5866-5875.
3. Ramanathan S., Mohammad S.S., Brilot F., Dale R.C. Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci 2014, 21:722-730.
4. Lancaster E., Martinez-Hernandez E., Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011, 77:179-189.
5. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010, 67:470-478.
6. Errichiello L., Perruolo G., Pascarella A., Formisano P., Minetti C., Striano S., et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 2009, 211:120-123.
7. Chernova O.B., Somerville R.P., Cowell J.K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881.
8. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
9. Fukata Y., Lovero K.L., Iwanaga T., Watanabe A., Yokoi N., Tabuchi K., et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 2010, 107:3799-3804.
10. Ohkawa T., Fukata Y., Yamasaki M., Miyazaki T., Yokoi N., Takashima H., et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013, 33:18161-18174.
11. Irani S.R., Michell A.W., Lang B., Pettingill P., Waters P., Johnson M.R., et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011, 69:892-900.
12. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008, 131:1940-1952.
13. Fanciulli M., Santulli L., Errichiello L., Barozzi C., Tomasi L., Rigon L., et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology 2012, 78:1299-1303.
14. Gu W., Brodtkorb E., Steinlein O.K. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 2002, 52:364-367.
15. Zhou Y.D., Lee S., Jin Z., Wright M., Smith S.E., Anderson M.P. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009, 15:1208-1214.
16. Yu Y.E., Wen L., Silva J., Li Z., Head K., Sossey-Alaoui K., et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 2010, 19:1702-1711.
17. Varley J., Vincent A., Irani S.R. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol 2015, 262:1081-1095.
18. Irani S.R., Buckley C., Vincent A., Cockerell O.C., Rudge P., Johnson M.R., et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008, 71:1647-1648.
19. Irani S.R., Stagg C.J., Schott J.M., Rosenthal C.R., Schneider S.A., Pettingill P., et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013, 136:3151-3162.
20. Andrade D.M., Tai P., Dalmau J., Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?. Neurology 2011, 76:1355-1357.
21. Striano P. Faciobrachial dystonic attacks: seizures or movement disorder?. Ann Neurol 2011, 70:179-180. [180].
22. Hertenstein E., Tang N.K., Bernstein C.J., Nissen C., Underwood M.R., Sandhu H.K. Sleep in patients with primary dystonia: a systematic review on the state of research and perspectives. Sleep Med Rev 2015, 26:95-107.
23. Lobbezoo F., Thu T.M., Remillard G., Montplaisir J.Y., Lavigne G.J. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci 1996, 23:285-290.
24. Isnard J., Guenot M., Sindou M., Mauguiere F. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia 2004, 45:1079-1090.
25. Proserpio P., Cossu M., Francione S., Tassi L., Mai R., Didato G., et al. Insular-opercular seizures manifesting with sleep-related paroxysmal motor behaviors: a stereo-EEG study. Epilepsia 2011, 52:1781-1791.
26. Ottman R., Winawer M.R., Kalachikov S., Barker-Cummings C., Gilliam T.C., Pedley T.A., et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004, 62:1120-1126.
27. Naasan G., Irani S.R., Bettcher B.M., Geschwind M.D., Gelfand J.M. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol 2014, 71:1300-1304.
28. Head K., Gong S., Joseph S., Wang C., Burkhardt T., Rossi M.R., et al. Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome 2007, 18:328-337.
29. Shin Y.W., Lee S.T., Shin J.W., Moon J., Lim J.A., Byun J.I., et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013, 265:75-81.